Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland W Sutter

Showing results (81-90 of 130) with videos related to

Pageof 13
Sort By:
The Journal of Infectious Diseases|May 2, 2003
Immunogenicity of measles and rubella vaccines in Oman: a prospective clinical trialKathryn A Kohler, Ali Jaffer M Suleiman, Susan E Robertson, et al.
The Journal of Infectious Diseases|March 31, 2010
Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in CubaSonia Resik, Alina Tejeda, Pedro Mas Lago, et al.
The Journal of Infectious Diseases|October 16, 2014
Poliovirus excretion among persons with primary immune deficiency disorders: summary of a seven-country study seriesLi Li, Olga Ivanova, Nadia Driss, et al.
Vaccine|July 22, 2014
Safety and immunogenicity of a primary series of Sabin-IPV with and without aluminum hydroxide in infantsPauline Verdijk, Nynke Y Rots, Monique G C T van Oijen, et al.
Vaccine|September 26, 2013
Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: a phase I trial in healthy adultsPauline Verdijk, Nynke Y Rots, Monique G C T van Oijen, et al.
The Journal of Infectious Diseases|January 12, 2017
Boosting Immune Responses Following Fractional-Dose Inactivated Poliovirus Vaccine: A Randomized, Controlled TrialSonia Resik, Alina Tejeda, Manuel Diaz, et al.
Vaccine|August 19, 2014
Reactogenicity and immunogenicity of inactivated poliovirus vaccine produced from Sabin strains: a phase I Trial in healthy adults in CubaSonia Resik, Alina Tejeda, Magilé Fonseca, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|December 23, 2006
Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradicationRadboud J Duintjer Tebbens, Mark A Pallansch, Olen M Kew, et al.
Vaccine|September 18, 2013
Survey of poliovirus antibodies in Kano, Northern NigeriaZubairu Iliyasu, Eric Nwaze, Harish Verma, et al.
Vaccine|June 5, 2007
Survey of poliovirus antibodies during the final stage of polio eradication in EgyptNasr El-Sayed, Samir Al-Jorf, Karen A Hennessey, et al.
Pageof 13

Showing results (81-90 of 130) with videos related to

Sort By:
Pageof 13
The Journal of Infectious Diseases|May 2, 2003
Immunogenicity of measles and rubella vaccines in Oman: a prospective clinical trialKathryn A Kohler, Ali Jaffer M Suleiman, Susan E Robertson, et al.
The Journal of Infectious Diseases|March 31, 2010
Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in CubaSonia Resik, Alina Tejeda, Pedro Mas Lago, et al.
The Journal of Infectious Diseases|October 16, 2014
Poliovirus excretion among persons with primary immune deficiency disorders: summary of a seven-country study seriesLi Li, Olga Ivanova, Nadia Driss, et al.
Vaccine|July 22, 2014
Safety and immunogenicity of a primary series of Sabin-IPV with and without aluminum hydroxide in infantsPauline Verdijk, Nynke Y Rots, Monique G C T van Oijen, et al.
Vaccine|September 26, 2013
Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: a phase I trial in healthy adultsPauline Verdijk, Nynke Y Rots, Monique G C T van Oijen, et al.
The Journal of Infectious Diseases|January 12, 2017
Boosting Immune Responses Following Fractional-Dose Inactivated Poliovirus Vaccine: A Randomized, Controlled TrialSonia Resik, Alina Tejeda, Manuel Diaz, et al.
Vaccine|August 19, 2014
Reactogenicity and immunogenicity of inactivated poliovirus vaccine produced from Sabin strains: a phase I Trial in healthy adults in CubaSonia Resik, Alina Tejeda, Magilé Fonseca, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|December 23, 2006
Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradicationRadboud J Duintjer Tebbens, Mark A Pallansch, Olen M Kew, et al.
Vaccine|September 18, 2013
Survey of poliovirus antibodies in Kano, Northern NigeriaZubairu Iliyasu, Eric Nwaze, Harish Verma, et al.
Vaccine|June 5, 2007
Survey of poliovirus antibodies during the final stage of polio eradication in EgyptNasr El-Sayed, Samir Al-Jorf, Karen A Hennessey, et al.
Pageof 13